カテゴリー： 世界, 医療/バイオ, QYResearch

ウデナフィルの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Udenafil Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10506）・商品コード：QY22JLX10506
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：73
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ウデナフィルのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にウデナフィルの世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ウデナフィルの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのウデナフィル市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ウデナフィルのグローバル主要企業には、Dong-A Pharmaceutical、Zydus Lifeなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ウデナフィル市場は、種類と用途によって区分されます。世界のウデナフィル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
100mg、200mg

【用途別セグメント】
病院薬局、民間クリニック、小売薬局、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ウデナフィル製品概要
- 種類別市場（100mg、200mg）
- 用途別市場（病院薬局、民間クリニック、小売薬局、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のウデナフィル販売量予測2017-2028
- 世界のウデナフィル売上予測2017-2028
- ウデナフィルの地域別販売量
- ウデナフィルの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ウデナフィル販売量
- 主要メーカー別ウデナフィル売上
- 主要メーカー別ウデナフィル価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（100mg、200mg）
- ウデナフィルの種類別販売量
- ウデナフィルの種類別売上
- ウデナフィルの種類別価格
・用途別市場規模（病院薬局、民間クリニック、小売薬局、その他）
- ウデナフィルの用途別販売量
- ウデナフィルの用途別売上
- ウデナフィルの用途別価格
・北米市場
- 北米のウデナフィル市場規模（種類別、用途別）
- 主要国別のウデナフィル市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのウデナフィル市場規模（種類別、用途別）
- 主要国別のウデナフィル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のウデナフィル市場規模（種類別、用途別）
- 主要国別のウデナフィル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のウデナフィル市場規模（種類別、用途別）
- 主要国別のウデナフィル市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのウデナフィル市場規模（種類別、用途別）
- 主要国別のウデナフィル市場規模（トルコ、サウジアラビア）
・企業情報
Dong-A Pharmaceutical、Zydus Life
・産業チェーン及び販売チャネル分析
- ウデナフィルの産業チェーン分析
- ウデナフィルの原材料
- ウデナフィルの生産プロセス
- ウデナフィルの販売及びマーケティング
- ウデナフィルの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ウデナフィルの産業動向
- ウデナフィルのマーケットドライバー
- ウデナフィルの課題
- ウデナフィルの阻害要因
・主な調査結果

Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.
Market Analysis and Insights: Global Udenafil Market
Due to the COVID-19 pandemic, the global Udenafil market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100mg accounting for % of the Udenafil global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Udenafil market size is valued at US$ million in 2021, while the US and Europe Udenafil are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Udenafil landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Udenafil include Dong-A Pharmaceutical and Zydus Life etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Udenafil Scope and Segment
Udenafil market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Udenafil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100mg
200mg
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
Others
By Company
Dong-A Pharmaceutical
Zydus Life
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Udenafil Product Introduction
1.2 Market by Type
1.2.1 Global Udenafil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100mg
1.2.3 200mg
1.3 Market by Application
1.3.1 Global Udenafil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Udenafil Sales Estimates and Forecasts 2017-2028
2.2 Global Udenafil Revenue Estimates and Forecasts 2017-2028
2.3 Global Udenafil Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Udenafil Sales by Region
2.4.1 Global Udenafil Sales by Region (2017-2022)
2.4.2 Global Sales Udenafil by Region (2023-2028)
2.5 Global Udenafil Revenue by Region
2.5.1 Global Udenafil Revenue by Region (2017-2022)
2.5.2 Global Udenafil Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Udenafil Sales by Manufacturers
3.1.1 Global Top Udenafil Manufacturers by Sales (2017-2022)
3.1.2 Global Udenafil Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Udenafil in 2021
3.2 Global Udenafil Revenue by Manufacturers
3.2.1 Global Udenafil Revenue by Manufacturers (2017-2022)
3.2.2 Global Udenafil Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Udenafil Revenue in 2021
3.3 Global Udenafil Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Udenafil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Udenafil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Udenafil Sales by Type
4.1.1 Global Udenafil Historical Sales by Type (2017-2022)
4.1.2 Global Udenafil Forecasted Sales by Type (2023-2028)
4.1.3 Global Udenafil Sales Market Share by Type (2017-2028)
4.2 Global Udenafil Revenue by Type
4.2.1 Global Udenafil Historical Revenue by Type (2017-2022)
4.2.2 Global Udenafil Forecasted Revenue by Type (2023-2028)
4.2.3 Global Udenafil Revenue Market Share by Type (2017-2028)
4.3 Global Udenafil Price by Type
4.3.1 Global Udenafil Price by Type (2017-2022)
4.3.2 Global Udenafil Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Udenafil Sales by Application
5.1.1 Global Udenafil Historical Sales by Application (2017-2022)
5.1.2 Global Udenafil Forecasted Sales by Application (2023-2028)
5.1.3 Global Udenafil Sales Market Share by Application (2017-2028)
5.2 Global Udenafil Revenue by Application
5.2.1 Global Udenafil Historical Revenue by Application (2017-2022)
5.2.2 Global Udenafil Forecasted Revenue by Application (2023-2028)
5.2.3 Global Udenafil Revenue Market Share by Application (2017-2028)
5.3 Global Udenafil Price by Application
5.3.1 Global Udenafil Price by Application (2017-2022)
5.3.2 Global Udenafil Price Forecast by Application (2023-2028)
6 North America
6.1 North America Udenafil Market Size by Type
6.1.1 North America Udenafil Sales by Type (2017-2028)
6.1.2 North America Udenafil Revenue by Type (2017-2028)
6.2 North America Udenafil Market Size by Application
6.2.1 North America Udenafil Sales by Application (2017-2028)
6.2.2 North America Udenafil Revenue by Application (2017-2028)
6.3 North America Udenafil Market Size by Country
6.3.1 North America Udenafil Sales by Country (2017-2028)
6.3.2 North America Udenafil Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Udenafil Market Size by Type
7.1.1 Europe Udenafil Sales by Type (2017-2028)
7.1.2 Europe Udenafil Revenue by Type (2017-2028)
7.2 Europe Udenafil Market Size by Application
7.2.1 Europe Udenafil Sales by Application (2017-2028)
7.2.2 Europe Udenafil Revenue by Application (2017-2028)
7.3 Europe Udenafil Market Size by Country
7.3.1 Europe Udenafil Sales by Country (2017-2028)
7.3.2 Europe Udenafil Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Udenafil Market Size by Type
8.1.1 Asia Pacific Udenafil Sales by Type (2017-2028)
8.1.2 Asia Pacific Udenafil Revenue by Type (2017-2028)
8.2 Asia Pacific Udenafil Market Size by Application
8.2.1 Asia Pacific Udenafil Sales by Application (2017-2028)
8.2.2 Asia Pacific Udenafil Revenue by Application (2017-2028)
8.3 Asia Pacific Udenafil Market Size by Region
8.3.1 Asia Pacific Udenafil Sales by Region (2017-2028)
8.3.2 Asia Pacific Udenafil Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Udenafil Market Size by Type
9.1.1 Latin America Udenafil Sales by Type (2017-2028)
9.1.2 Latin America Udenafil Revenue by Type (2017-2028)
9.2 Latin America Udenafil Market Size by Application
9.2.1 Latin America Udenafil Sales by Application (2017-2028)
9.2.2 Latin America Udenafil Revenue by Application (2017-2028)
9.3 Latin America Udenafil Market Size by Country
9.3.1 Latin America Udenafil Sales by Country (2017-2028)
9.3.2 Latin America Udenafil Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Udenafil Market Size by Type
10.1.1 Middle East and Africa Udenafil Sales by Type (2017-2028)
10.1.2 Middle East and Africa Udenafil Revenue by Type (2017-2028)
10.2 Middle East and Africa Udenafil Market Size by Application
10.2.1 Middle East and Africa Udenafil Sales by Application (2017-2028)
10.2.2 Middle East and Africa Udenafil Revenue by Application (2017-2028)
10.3 Middle East and Africa Udenafil Market Size by Country
10.3.1 Middle East and Africa Udenafil Sales by Country (2017-2028)
10.3.2 Middle East and Africa Udenafil Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dong-A Pharmaceutical
11.1.1 Dong-A Pharmaceutical Corporation Information
11.1.2 Dong-A Pharmaceutical Overview
11.1.3 Dong-A Pharmaceutical Udenafil Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dong-A Pharmaceutical Udenafil Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dong-A Pharmaceutical Recent Developments
11.2 Zydus Life
11.2.1 Zydus Life Corporation Information
11.2.2 Zydus Life Overview
11.2.3 Zydus Life Udenafil Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Zydus Life Udenafil Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zydus Life Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Udenafil Industry Chain Analysis
12.2 Udenafil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Udenafil Production Mode & Process
12.4 Udenafil Sales and Marketing
12.4.1 Udenafil Sales Channels
12.4.2 Udenafil Distributors
12.5 Udenafil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Udenafil Industry Trends
13.2 Udenafil Market Drivers
13.3 Udenafil Market Challenges
13.4 Udenafil Market Restraints
14 Key Findings in The Global Udenafil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Udenafil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100mg
Table 3. Major Manufacturers of 200mg
Table 4. Global Udenafil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Udenafil Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Udenafil Sales by Region (2017-2022) & (K Units)
Table 7. Global Udenafil Sales Market Share by Region (2017-2022)
Table 8. Global Udenafil Sales by Region (2023-2028) & (K Units)
Table 9. Global Udenafil Sales Market Share by Region (2023-2028)
Table 10. Global Udenafil Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Udenafil Revenue Market Share by Region (2017-2022)
Table 12. Global Udenafil Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Udenafil Revenue Market Share by Region (2023-2028)
Table 14. Global Udenafil Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Udenafil Sales Share by Manufacturers (2017-2022)
Table 16. Global Udenafil Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Udenafil Revenue Share by Manufacturers (2017-2022)
Table 18. Udenafil Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Udenafil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Udenafil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Udenafil as of 2021)
Table 21. Udenafil Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Udenafil Product Offered
Table 23. Date of Manufacturers Enter into Udenafil Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Udenafil Sales by Type (2017-2022) & (K Units)
Table 26. Global Udenafil Sales by Type (2023-2028) & (K Units)
Table 27. Global Udenafil Sales Share by Type (2017-2022)
Table 28. Global Udenafil Sales Share by Type (2023-2028)
Table 29. Global Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Udenafil Revenue Share by Type (2017-2022)
Table 32. Global Udenafil Revenue Share by Type (2023-2028)
Table 33. Udenafil Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Udenafil Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Udenafil Sales by Application (2017-2022) & (K Units)
Table 36. Global Udenafil Sales by Application (2023-2028) & (K Units)
Table 37. Global Udenafil Sales Share by Application (2017-2022)
Table 38. Global Udenafil Sales Share by Application (2023-2028)
Table 39. Global Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Udenafil Revenue Share by Application (2017-2022)
Table 42. Global Udenafil Revenue Share by Application (2023-2028)
Table 43. Udenafil Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Udenafil Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Udenafil Sales by Type (2017-2022) & (K Units)
Table 46. North America Udenafil Sales by Type (2023-2028) & (K Units)
Table 47. North America Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Udenafil Sales by Application (2017-2022) & (K Units)
Table 50. North America Udenafil Sales by Application (2023-2028) & (K Units)
Table 51. North America Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Udenafil Sales by Country (2017-2022) & (K Units)
Table 54. North America Udenafil Sales by Country (2023-2028) & (K Units)
Table 55. North America Udenafil Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Udenafil Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Udenafil Sales by Type (2017-2022) & (K Units)
Table 58. Europe Udenafil Sales by Type (2023-2028) & (K Units)
Table 59. Europe Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Udenafil Sales by Application (2017-2022) & (K Units)
Table 62. Europe Udenafil Sales by Application (2023-2028) & (K Units)
Table 63. Europe Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Udenafil Sales by Country (2017-2022) & (K Units)
Table 66. Europe Udenafil Sales by Country (2023-2028) & (K Units)
Table 67. Europe Udenafil Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Udenafil Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Udenafil Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Udenafil Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Udenafil Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Udenafil Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Udenafil Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Udenafil Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Udenafil Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Udenafil Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Udenafil Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Udenafil Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Udenafil Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Udenafil Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Udenafil Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Udenafil Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Udenafil Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Udenafil Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Udenafil Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Udenafil Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Udenafil Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Udenafil Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Udenafil Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Udenafil Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Udenafil Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Udenafil Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Udenafil Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Udenafil Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Udenafil Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Udenafil Revenue by Country (2023-2028) & (US$ Million)
Table 105. Dong-A Pharmaceutical Corporation Information
Table 106. Dong-A Pharmaceutical Description and Major Businesses
Table 107. Dong-A Pharmaceutical Udenafil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Dong-A Pharmaceutical Udenafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Dong-A Pharmaceutical Recent Developments
Table 110. Zydus Life Corporation Information
Table 111. Zydus Life Description and Major Businesses
Table 112. Zydus Life Udenafil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Zydus Life Udenafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Zydus Life Recent Developments
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Udenafil Distributors List
Table 118. Udenafil Customers List
Table 119. Udenafil Market Trends
Table 120. Udenafil Market Drivers
Table 121. Udenafil Market Challenges
Table 122. Udenafil Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Udenafil Product Picture
Figure 3. Global Udenafil Market Share by Type in 2021 & 2028
Figure 3. 100mg Product Picture
Figure 4. 200mg Product Picture
Figure 5. Global Udenafil Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacies
Figure 7. Private Clinics
Figure 8. Retail Pharmacies
Figure 9. Others
Figure 10. Udenafil Report Years Considered
Figure 11. Global Udenafil Sales 2017-2028 (K Units)
Figure 12. Global Udenafil Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Udenafil Revenue 2017-2028 (US$ Million)
Figure 14. Global Udenafil Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Udenafil Sales Market Share by Region (2017-2022)
Figure 16. Global Udenafil Sales Market Share by Region (2023-2028)
Figure 17. North America Udenafil Sales YoY (2017-2028) & (K Units)
Figure 18. North America Udenafil Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Udenafil Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Udenafil Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Udenafil Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Udenafil Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Udenafil Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Udenafil Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Udenafil Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Udenafil Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Udenafil Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Udenafil in the World: Market Share by Udenafil Revenue in 2021
Figure 29. Global Udenafil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Udenafil Sales Market Share by Type (2017-2028)
Figure 31. Global Udenafil Revenue Market Share by Type (2017-2028)
Figure 32. Global Udenafil Sales Market Share by Application (2017-2028)
Figure 33. Global Udenafil Revenue Market Share by Application (2017-2028)
Figure 34. North America Udenafil Sales Market Share by Type (2017-2028)
Figure 35. North America Udenafil Revenue Market Share by Type (2017-2028)
Figure 36. North America Udenafil Sales Market Share by Application (2017-2028)
Figure 37. North America Udenafil Revenue Market Share by Application (2017-2028)
Figure 38. North America Udenafil Sales Share by Country (2017-2028)
Figure 39. North America Udenafil Revenue Share by Country (2017-2028)
Figure 40. United States Udenafil Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Udenafil Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Udenafil Sales Market Share by Type (2017-2028)
Figure 43. Europe Udenafil Revenue Market Share by Type (2017-2028)
Figure 44. Europe Udenafil Sales Market Share by Application (2017-2028)
Figure 45. Europe Udenafil Revenue Market Share by Application (2017-2028)
Figure 46. Europe Udenafil Sales Share by Country (2017-2028)
Figure 47. Europe Udenafil Revenue Share by Country (2017-2028)
Figure 48. Germany Udenafil Revenue (2017-2028) & (US$ Million)
Figure 49. France Udenafil Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Udenafil Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Udenafil Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Udenafil Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Udenafil Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Udenafil Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Udenafil Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Udenafil Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Udenafil Revenue Share by Region (2017-2028)
Figure 59. China Udenafil Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Udenafil Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Udenafil Revenue (2017-2028) & (US$ Million)
Figure 62. India Udenafil Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Udenafil Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Udenafil Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Udenafil Sales Market Share by Type (2017-2028)
Figure 69. Latin America Udenafil Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Udenafil Sales Market Share by Application (2017-2028)
Figure 71. Latin America Udenafil Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Udenafil Sales Share by Country (2017-2028)
Figure 73. Latin America Udenafil Revenue Share by Country (2017-2028)
Figure 74. Mexico Udenafil Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Udenafil Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Udenafil Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Udenafil Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Udenafil Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Udenafil Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Udenafil Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Udenafil Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Udenafil Revenue Share by Country (2017-2028)
Figure 84. Turkey Udenafil Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Udenafil Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Udenafil Revenue (2017-2028) & (US$ Million)
Figure 87. Udenafil Value Chain
Figure 88. Udenafil Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[ウデナフィルの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10506)販売に関する免責事項を必ずご確認ください。
★調査レポート[ウデナフィルの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のウデナフィル市場2022年：100mg、200mg
  • アジュバントペプチドの世界市場インサイト・予測（～2028年）
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • ダラツムマブ注射の世界市場インサイト・予測（～2028年）
  • デノスマブの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆